Molecular Biology Reports

, Volume 23, Issue 3–4, pp 191–195 | Cite as

Internalization of anti-nucleolin antibody into viable HEp-2 cells

  • Jau-Shyong Deng
  • Byron Ballou
  • Joseph K. Hofmeister
Autoantibodies as Clinical Markers


Anti-nucleolin antibodies have been detected in patients with systemic connective tissue diseases (SCTD) including systemic sclerosis (SSc) and systemic lupus erythematosus (SLE). In vivo bound autoantibodies to nucleoli of epidermal keratinocytes have been demonstrated in skin from patients with SCTD. In this study, monoclonal antibody to nucleolin (D-3) was used to determine the distribution of nucleolin in different culture cells including HEp-2, HepG2, HRCC, Molt-4 and Wil2 cells. Nucleolin was found to be present on the surface of HEp-2 and HepG2 cells, but not on the surface of HRCC and lymphoblastoid (Molt-4 and Wil2) cells; in contrast, nucleolin was detected in the nucleoli of all permeabilized cells examined. In immunoprecipitation, using extracts from 32P-labeled HEp-2 cells as antigenic source, cell membrane as well as nuclear nucleolins were found to be phosphorylated with a molecular weight of 105 kDa. Viable HEp-2 and HepG2 cells were cocultured with IgG fraction of D-3 in a CO2 incubator for 1 to 24 h, and then permeabilized with acetone followed by immunofluorescence staining with FITC-labeled goat anti-mouse IgG antibodies. Nucleolar staining was observed in cells after 10 h or longer of coculture. These data indicated that D-3 antibody reacted with cell membrane nucleolin and subsequently gain access into cells in a process related to pinocytosis.

Key words

in vivo antinuclear antibody nucleolin 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Olson MOJ & Busch H (1978) In: Skin GI and Kleinsmith L (eds) Methods in Chromosomal Protein Research (pp 163–210) Academic Press, Inc, New YorkGoogle Scholar
  2. 2.
    Olson MOJ, Guetzow K & Busch H (1981) Exp. Cell. Res. 135: 259–265Google Scholar
  3. 3.
    Bugler B, Caizergues-Ferrer M, Bouche G, Bourbon H & Amalric F (1982) Eur. J. Biochem. 128: 475–480Google Scholar
  4. 4.
    Bouche G, Caizergues-Ferrer M, Bugler B & Amalric F (1984) Nucleic. Acid. Res. 12:3025–3035Google Scholar
  5. 5.
    Semenkovich CF, Ostlund RE, Olson MOJ & Yang JW (1990) Biochemistry 29: 708–713Google Scholar
  6. 6.
    Tan EM: Antinuclear antibodies (1989) Adv. Immunol. 44: 93–151Google Scholar
  7. 7.
    Prystowsky DS, Gilliam JN & Tuffanelli DL (1978) Arch. Dermatol. 114: 536–538Google Scholar
  8. 8.
    Deng JS & Ballou BR (1993) J. Invest. Derm. 100: 527Google Scholar
  9. 9.
    Ballou BT, Fisher G, Deng JS, Reiland JM, Waggoner AS & Hakala TR (1993) FASEB J. 7: 1308Google Scholar
  10. 10.
    Deng JS & Kumar V (1987) In: Beutner EH, Chorzelski TP & Kumar V (eds) Immunopathology of the skin, 3rd edition (pp 533–553) John Wiley & Sons, New YorkGoogle Scholar
  11. 11.
    Liebert M, Ballou BT, Taylor RJ, Reiland JM & Hakala TR (1985) J. Immunol. Methods 85: 97–104Google Scholar
  12. 12.
    West MA, Bretscher MS & Watts C (1989) J. Cell. Biol. 109: 2731–2739Google Scholar
  13. 13.
    Kovacsovics-Bankowski M, Clark K, Benacerraf B & Rock KL (1993) Proc. Natl. Acad. Sci. (USA) 90: 4942–4946Google Scholar
  14. 14.
    Srivastava M, Fleming PJ, Pollard HB & Burns AL (1989) FEBS Lett. 250: 99–105Google Scholar
  15. 15.
    Lischwe MA, Richards RL, Busch RK & Busch M (1981) Exp. Cell. Res. 136: 101–105Google Scholar
  16. 16.
    Chen CM, Chiang SY & Yeh NS (1991) J. Biol. Chem. 266: 7754–7758Google Scholar
  17. 17.
    Sapp M, Richter A, Weisshart K, Caizergues-Ferrer M, Amalric F, Wallace MO, Kirstein MN & Olson MOJ (1989) Eur. J. Biochem. 179: 541–548Google Scholar
  18. 18.
    Ballou B, Fisher GW, Deng JS, Reiland JM, Hakala TR, Srivastava M & Farkas DL (1996) Proc. Soc. Photo-Optical Instrum. Eng. 2680: 123–131Google Scholar

Copyright information

© Kluwer Academic Publishers 1996

Authors and Affiliations

  • Jau-Shyong Deng
    • 1
    • 2
  • Byron Ballou
    • 3
  • Joseph K. Hofmeister
    • 1
  1. 1.Medical Service, Department of Veterans Affairs Medical CenterUniversity Drive CPittsburghUSA
  2. 2.Department of DermatologyUniversity of Pittsburgh School of MedicinePittsburghUSA
  3. 3.Department of SurgeryUniversity of Pittsburgh School of MedicinePittsburghUSA

Personalised recommendations